Trevi Therapeutics (TRVI) Return on Capital Employed (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -264.00 |
| Dec 31, 2025 | -4.00 |
| Sep 30, 2025 | 817.00 |
| Jun 30, 2025 | 1,499.00 |
| Mar 31, 2025 | 1,595.00 |
| Dec 31, 2024 | 1,257.00 |
| Sep 30, 2024 | -1,529.00 |
| Jun 30, 2024 | -1,356.00 |
| Mar 31, 2024 | -955.00 |
| Dec 31, 2023 | -514.00 |
| Sep 30, 2023 | -408.00 |
| Jun 30, 2023 | -124.00 |
| Mar 31, 2023 | -198.00 |
| Dec 31, 2022 | 830.00 |
| Sep 30, 2022 | 3,937.00 |
| Jun 30, 2022 | 7,138.00 |
| Mar 31, 2022 | -11.00 |
| Dec 31, 2021 | -1,438.00 |
| Sep 30, 2021 | -2,454.00 |
| Jun 30, 2021 | -2,610.00 |
| Mar 31, 2021 | -983.00 |
| Dec 31, 2020 | -440.00 |
| Sep 30, 2020 | 317.00 |
| Jun 30, 2020 | -843.00 |
| Mar 31, 2020 | -1,496.00 |
| Dec 31, 2019 | -671.00 |
| Sep 30, 2019 | 1,982.00 |
| Jun 30, 2019 | 13,783.00 |